Thursday, August 08, 2024 4:15:05 PM
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
Source: PR Newswire (US)
Separation activities and business continuity on track
Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
Generated $355 million in cash from operations; free cash flow1 of $297 million
Raises full-year 2024 organic sales growth and adjusted EPS guidance
ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.
Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)
"As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
Source: PR Newswire (US)
Separation activities and business continuity on track
Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
Generated $355 million in cash from operations; free cash flow1 of $297 million
Raises full-year 2024 organic sales growth and adjusted EPS guidance
ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.
Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)
"As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
Recent SOLV News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:10:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:09:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:54 PM
- Solventum to Participate in the 2026 BofA Securities Health Care Conference • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 09:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:08:36 PM
- Solventum Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/05/2026 08:05:00 PM
- Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck • GlobeNewswire Inc. • 04/30/2026 05:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 04:59:19 PM
- Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 • PR Newswire (US) • 04/14/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2026 08:17:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:35:11 PM
- Solventum to Participate in the 2026 KeyBanc Healthcare Forum • PR Newswire (US) • 03/11/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:47:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:08:05 PM
- Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance • PR Newswire (US) • 02/26/2026 09:05:00 PM
- Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 • PR Newswire (US) • 02/03/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 03:01:46 PM
- Solventum Completes Acquisition of Acera Surgical • PR Newswire (US) • 12/23/2025 09:05:00 PM
- Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy • PR Newswire (US) • 12/17/2025 09:05:00 PM
- Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength • PR Newswire (US) • 12/16/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 02:02:04 PM
